Each year, heart disease contributes to 18 million deaths worldwide and drains more than $200 billion from the U.S. economy. Yet, there has been just one approved drug in twenty years. We embrace this  call to action.

Today, the CCB is poised to build on the University of Washington?s legacy of leadership in cardiovascular research. We are attacking the problem at the point of impact, leveraging advances in technology, building a pipeline from the lab to the clinic and the private sector, publishing game-changing research, partnering with peer institutes, and recruiting and retaining talent at all levels who share our commitment to basic science and community health.